SCHEMBL5571833

SCHEMBL5571833

[CH2]CC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27316832 0.96
SCHEMBL2474632 0.72
SCHEMBL18741 0.70
SCHEMBL8381959 0.69
SCHEMBL292473 0.67 OR51E2 (0.53)
SCHEMBL14353604 0.67
SCHEMBL361798 0.67 OR51E2 (0.79)
SCHEMBL8607291 0.67
SCHEMBL22191894 0.67
SCHEMBL8572195 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107602409-A Brominated laminine ester group oxamides and its synthetic method and application with active anticancer 青岛大学 2018-01-19 CN claimed
US-20050076578-A1 Tunable composition and method for chemical-mechanical planarization with aspartic acid/tolyltriazole VERSUM MATERIALS US, LLC 2005-04-14 US claimed
CN-1038836-A Novel aminotransferase, its production and use HOECHST AG (DE) 1990-01-17 CN claimed
CN-107602409-A Brominated laminine ester group oxamides and its synthetic method and application with active anticancer 青岛大学 2018-01-19 CN disclosed
EP-1819693-A1 ANTITHROMBOTIC DIAMIDES ELI LILLY AND COMPANY (US) 2007-08-22 EP disclosed
WO-2006057868-A1 ANTITHROMBOTIC DIAMIDES ELI LILLY AND COMPANY (US) 2006-06-01 WO disclosed
EP-1487789-A2 IMPROVEMENTS IN PHARMACEUTICAL COMPOSITIONS Charterhouse Therapeutics Ltd. (GB) 2004-12-22 EP disclosed
WO-2003082813-A2 IMPROVEMENTS IN PHARMACEUTICAL COMPOSITIONS CHARTERHOUSE THERAPEUTICS LIMITED (GB) 2003-10-09 WO disclosed
EP-1240171-A1 CYCLOPENTENEONE DERIVATIVES Charterhouse Therapeutics Ltd. (GB) 2002-09-18 EP disclosed
CN-1087347-C Application of new aminotransferase in amino transfer HOECHST AG (DE) 2002-07-10 CN disclosed
EP-1124804-A1 PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS ABBOTT LABORATORIES (US) 2001-08-22 EP disclosed
EP-0282895-B1 2-oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMA CO LTD (JP) 1995-06-07 EP disclosed
CN-1023801-C 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMA CO LTD (JP) 1994-02-16 CN disclosed
US-5037976-A Antimicrobial Agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-06 US disclosed
US-4898859-A 2-Oxa-isocephem compounds and compositions containing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-02-06 US disclosed
CN-88102161-A 2-oxa-isocephem compounds, compositions containing them and processes for their preparation 1988-10-05 CN disclosed
EP-0282895-A2 2-oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-09-21 EP disclosed
EP-0238969-A1 Cyclobutane diester-dinitriles process for their preparation and their use BAYER AG (DE) 1987-09-30 EP disclosed
EP-0131757-A1 Disazo dyestuffs of the isothiazole series BASF Aktiengesellschaft (DE) 1985-01-23 EP disclosed
US-4207233-A Azo dyes containing a thiazole component BASF AKTIENGESELLSCHAFT (DE) 1980-06-10 US disclosed